DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$6.37
-0.08 (-1.24%)
Open$6.43
Previous Close$6.45
Day High$6.54
Day Low$6.20
52W High$9.56
52W Low$4.31
Volume—
Avg Volume170.7K
Market Cap177.05M
P/E Ratio—
EPS$-0.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+145.8% upside
Current
$6.37
$6.37
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 70.18M | 74.39M | 106.46M |
| Net Income | -12,968,634 | -12,372,027 | 19.04M |
| Profit Margin | -18.5% | -17.6% | 17.9% |
| EBITDA | -4,441,465 | -4,472,537 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -5.7% | -5.7% | +23.5% |
| Debt/Equity | 0.79 | 0.79 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |